The attempt of counteracting IL-22 effects in transformed keratinocytes arises from recent studies from our laboratory showing that IL-22 is abundantly secreted by TILs infiltrating BCC and SCC lesions, and, together with IL-17, it displays has tumorigenic functions in these pathological contexts [10]. This evidence concerns the gene IL22 and skin basal cell carcinoma.